Publikation

Is Pertuzumab Plus Trastuzumab Without Chemotherapy a Reasonable Treatment for ERBB2-Positive Metastatic Breast Cancer?-Reply.

Wissenschaftlicher Artikel/Review - 08.02.2024

Huober Jens, Thürlimann Beat, Dietrich Daniel